UnitedHealth Group is trading at $384.40, up 3.63%, with no verified company-specific catalyst tied to the October 9 advance.
- Reports cite mixed signals: TD Cowen cut its price target, while Piper Sandler highlighted Star Ratings stability and a positive view.
- Healthcare was down 1.49%, so sector weakness does not explain the gain; major indexes were modestly higher in the supplied market context.